Roche cancer drug suffers patent setback in India<p><a href="http://news.yahoo.com/roche-cancer-drug-suffers-patent-setback-india-152300508.html"><img src="http://l3.yimg.com/bt/api/res/1.2/VbfxwwlwH86VDrHfgRWvsg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-08-04T102047Z_1_CBRE9730SQU00_RTROPTP_2_ALEXION-ROCHE.JPG" width="130" height="86" alt="File of the logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf" align="left" title="File of the logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf" border="0" /></a>ZURICH (Reuters) - India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday, in the latest regulatory setback for western drugmakers trying to crack the fast-growing market. A Roche spokesman said the company was considering what further course of action to take. The Kolkata Patent Office said on Monday the company had failed to file its patent applications for Herceptin correctly and the patents had not been revoked. Roche declined to comment on that statement. ...</p><br clear="all"/>
Source: Roche cancer drug suffers patent setback in India (http://news.yahoo.com/roche-cancer-drug-suffers-patent-setback-india-152300508.html)